- Home
- HIMS vs BRKR Comparison
HIMS vs BRKR Comparison
Compare HIMS & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HIMS | BRKR |
|---|---|---|
| Founded | 2017 | 1960 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.0B | 6.2B |
| IPO Year | 2019 | 2000 |
Fundamental Metrics
Financial Performance| Metric | HIMS | BRKR |
|---|---|---|
| Price | $27.23 | $36.80 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 15 | 13 |
| Target Price | $30.46 | ★ $48.54 |
| AVG Volume (30 Days) | ★ 29.2M | 1.6M |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 0.58% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 0.51 | N/A |
| Revenue | ★ $2,347,637,000.00 | $1,895,600,000.00 |
| Revenue This Year | $19.82 | $6.30 |
| Revenue Next Year | $19.23 | $3.81 |
| P/E Ratio | $51.63 | ★ N/A |
| Revenue Growth | ★ 59.00 | N/A |
| 52 Week Low | $13.74 | $28.53 |
| 52 Week High | $70.43 | $56.22 |
Technical Indicators
Market Signals| Indicator | HIMS | BRKR |
|---|---|---|
| Relative Strength Index (RSI) | 56.12 | 46.96 |
| Support Level | $18.62 | $35.86 |
| Resistance Level | $27.54 | $41.74 |
| Average True Range (ATR) | 2.40 | 1.75 |
| MACD | 0.05 | -0.39 |
| Stochastic Oscillator | 62.92 | 32.17 |
Price Performance
Historical ComparisonAbout HIMS Hims & Hers Health Inc.
Hims & Hers, launched in 2017, is a telehealth platform that connects patients and healthcare providers to offer treatment options for specialties like erectile dysfunction, hair loss, skin care, mental health, and weight loss. Its offerings include generic, branded, and compounded prescription drugs as well as over-the-counter medicines, cosmetics, and supplements. The platform, which has more than 2 million subscribers, is available in all 50 states and certain European markets like the UK. It includes provider networks, electronic medical records, cloud pharmacy fulfillment, and personalization capabilities. Hims does not take insurance and only accepts payments directly from customers.
About BRKR Bruker Corporation
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.